Lilly Hero Image

Eli Lilly and Company

Lilly unites caring with discovery to make life better for people around the world.

Lilly Corporate Center

893 South Delaware

Indianapolis, IN 46285


+1 (317) 276-2000


Jim Martinez Thumbnail

Researcher Profile: Jim Martinez, MD

Promising results from clinical trials of CGRP inhibitors bring renewed hope for patients with cluster headache. 

Diabetes MiD Thumbnail

Diabetes: Ensuring Innovation Reaches Patients

Innovative new treatments for diabetes means that patients can go about their days with less worry.

New Era For Treatments in Migraine Thumbnail

A New Era In Treatments For Migraine

Reducing unnecessary suffering resulting from migraine is beneficial to both individual patients and to society.

Researcher Profile: Christina Kiley image

Researcher Profile: Christina Kiley

Through her roles at Eli Lilly and Company, Dr. Christina Kiley developed a strong understanding of the patient perspective and the diverse ways patients are incorporated into biopharmaceutical research.

Disrupting Alzheimer's Disease thumbnail

Disrupting Alzheimer's Disease

Researchers, patient advocates and policymakers recently gathered in Chicago to discuss the unique challenges that make up Alzheimer's research and what the future holds for the 5.7 million Americans living with the disease.

Innovation is Fragile, But Worth Protecting thumbnail

Innovation is Fragile, But Worth Protecting

The Atlantic, in partnership with PhRMA's GOBOLDLY campaign, convened thought leaders to discuss the policies needed to foster biopharmaceutical innovation while ensuring access and affordability for patients.

Researcher Profile: Jirong Lu image

Researcher Profile: Jirong Lu

Dr. Jirong Lu, a distinguished research fellow at Eli Lilly and Company (Lilly), traces the beginnings of her career to a high school fascination with chemistry.

Getting Ahead of Migraines image

Getting Ahead of Migraines

Understanding migraines fully can give patients back time taken by the disease.

Ensuring Innovation to Disease Affecting Women image

Ensuring Innovation in Diseases Affecting Women

When women seek medical care, they may be up against different obstacles from men.

Migraine: More Than Just A Headache image

Migraine: More than Just a Bad Headache

Migraine is a debilitating neurological disease that is often misunderstood by those who do not suffer symptoms, according to the Migraine Impact Report, a new survey recently released by Eli Lilly and Company and conducted by Nielsen.

Researcher Profile: Laura Michael image

Researcher Profile: Laura Michael

Dr. Laura Michael started her career at Lilly researching cardiovascular disease and the complications that frequently arise from it.

From Technology to Treatment: Uncovering Cures for Brain Diseases image

From Technology to Treatment: Uncovering Cures for Brain Diseases

The brain is one of the most complex – and most fascinating – organs in the human body, and one that can be impacted by countless diseases and disorders.

Combating Type 2 Diabetes image

Combating Type 2 Diabetes

New innovative treatments are revolutionizing life for patients battling diabetes.

Advancing Innovation in San Diego image

Advancing Innovation in San Diego

As a senior research advisor at the Eli Lilly and Co. Biotechnology Center in San Diego, Stephen Demarest delivers innovative and novel therapeutics to treat challenging diseases such as cancer and autoimmunity.

Researcher Profile: Dan Skovronsky image

Researcher Profile: Dan Skovronsky

A neuroscientist and neuropathologist by training, Dan is responsible for development across all of Lilly's products - from clinical trials through approvals - specifically working within the areas of oncology, diabetes, Alzheimer's disease, immunology and pain management.

On the Front Lines of Science image

On the Front Lines of Science

In recent years, medical breakthroughs including new drug therapies and early disease monitoring technologies have accelerated rapidly. This has created wide-ranging transformations in patient care.

America's Biopharmaceutical Industry Is Central to Diverse R&D Ecosystem image

America's Biopharmaceutical Industry Is Central to Diverse R&D Ecosystem

America's biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that supports continued medical advances for patients.

Research Doesn’t End on A Medicine’s Approval image

Research Doesn’t End On A Medicine’s Approval

Research on a medicine doesn't end on the initial approval by the FDA. Eli Lilly and Company's chief medical officer shares why ongoing research helps us better understand a medicine's full value.